PINC Research is bearish on GlaxoSmithKline Pharma and has recommended sell rating on the stock with a target of Rs 1754 in its February 21, 2011 research report.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!